Neurodegenerative diseases - Treatment
Coenzyme Q(10) and its effects in the treatment of neurodegenerative diseases
... complications, treatment with antioxidants has been used as a therapeutic approach in several types of neurodegenerative diseases, including AD (Ahmad et ...
12
Use of ipscs for the treatment of neurodegenerative diseases
... Only a limited number of drugs are currently available for the treatment of neurodegenerative diseases. Despite increased investment in research and development in the last decades, that has not ...
66
Dalbergia ecastaphyllum leaf extracts: in vitro inhibitory against enzymes related to metabolic syndrome, inflammation and neurodegenerative diseases
... therapeutic treatment of several diseases such as Alzheimer, Parkinson, type 2 diabetes mellitus, hyperglycemia, and pigmentation, as well as those associated with oxidative ...
10
ASYN and tau interaction : new drug target for neurodegenerative diseases
... the treatment with ferrous ions leads to increased cytotoxicity related to increased inclusions formation and oxidative stress markers such as ROS [347,364] together with ASYN-mediated release of typical yeast ...
113
Oxidative stress in neurodegenerative diseases: Mechanisms and therapeutic perspectives
... The treatment of neurob- lastoma cells (SK-N-MC) with low doses of antimycin A1, which is a mitochondrial complex III inhibitor, and 2-deoxy- D-glucose moderately impaired cellular functions by a longer lasting ...
15
Telemedicine multimedia systems to support neurodegenerative diseases participatory management
... Hospital São João (HSJ) in Porto, besides being one of the major hospitals in Portugal (around 1000 beds), is a pioneer and leader in PD diagnosis and treatment, therefore dealing with pa- tients from every region ...
132
Discovery of target directed drugs for neurodegenerative diseases based on benzopyrone scaffold
... of neurodegenerative diseases (ND), mainly Parkinson (PD) and Alzheimer (AD) ...effective treatment, with the drugs that are available being only used to delay the progress of neurodegeneration by ...
307
Specific transfection of inflamed brain by macrophages: a new therapeutic strategy for neurodegenerative diseases.
... 6-OHDA treatment caused significant microglia activation and neuronal loss, administration of catalase-transfected macrophages dramatically decreased oxidative stress, and increased neuronal ...
16
High-throughput platforms for the screening of new therapeutic targets for neurodegenerative diseases
... the one found in vivo in the target tissue or system unit of interest. Although simple in vitro systems are appealing, there is a need to find equilibrium between model simplicity and physiological relevancy for data ...
25
Development of the CHARIOT Research Register for the Prevention of Alzheimer's Dementia and Other Late Onset Neurodegenerative Diseases.
... into treatment trials for dementia [24] and the Banner Alzheimer’s Institute has initiated a USA-based register of indi- viduals interested in learning about prevention studies ...
14
Polyphenols and Neurodegenerative Diseases
... disorders like Alzheimer’s and Parkinson’s disease is growing, as well as the economic burden of its care and treatment. In this light, the preventive and therapeutic benefits of dietary polyphenols may directly ...
46
Advanced techniques in bioimage analysis for the study of neurodegenerative diseases - reconstruction and morphometric analysis of dendritic spines
... The first is a geometrical method capable of detecting and characterizing the morphology of 3D dendritic spines; the second is a supervised method based on Deep Learning and capable of d[r] ...
126
Treatment as a factor in the control of the venereal diseases
... If it is true that early syphilis can be effectively treated when an effective blood leve1 of penicillin is maintained for 72 hours, then it is only necessary to [r] ...
7
Bisphosphonates in the treatment of metabolic bone diseases
... GC treatment with alendronate 5 or 10 mg/day preserved bone density reducing the risk of morpho- metric vertebral fractures ...and treatment for glucocorticoid-induced ...
7
PCSK9 Inhibitors in the Treatment of Cardiovascular Diseases: A Narrative Review
... In this review, among the treatment targets and goals for CVD prevention, the author will focus only in hypercholesteremia. LDL-cholesterol (LDL-c) is a well-established and modifiable risk factor for CVD. ...
37
Celastrol: A Spectrum of Treatment Opportunities in Chronic Diseases
... inflammatory diseases, namely, rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel diseases, osteoarthritis and allergy, as well as in cancer, neurodegenerative disorders and other ...
18
Treatment networks and associations of patients with rare diseases
... rare diseases, and they are sometimes included in social movements in ...Rare Diseases was enacted in 2014, patients still struggle to ensure access to and treatment by the Unified Health ...rare ...
10
Punction methods of diagnostics and treatment of thyroid diseases
... у больных вторичным лимфостазом нижних конечностей, на фоне рецидивирующих ро- жистых воспалений, после проведённого консерва- тивного курса лечения с применением эндолимфати- че[r] ...
4
Probiotics and the treatment of peri-implant diseases: a systematic review
... Randomized controlled trials (RCTs) represent the gold standard for examining the success of medical interventions and are generally regarded as the most reliable source of scientific evidence (44). These studies are ...
58
Perspectives on the modeling of the neuromusculoskeletal system to investigate the influence of neurodegenerative diseases on sensorimotor control
... It is important to notice that ALS (like other neurodegenerative diseases) can also affect muscle properties and, consequently, joint dynamics. Schmied et al. (1999) showed that ALS patients exhibited a ...
12